Wanbury refinances $150 cr debt, cuts interest costs significantly
[ad_1] Wanbury Limited, a pharmaceutical company with global API and domestic formulations operations, announced today it has successfully refinanced ₹150 crore of outstanding debt at a reduced interest rate of…